Skip to content

Combining Ancient & New

Phytonix’s technology integrates 21st century scientific ingenuity with the ancient and elegant process of photosynthesis. We believe that this combination holds great potential to provide for civilizations’ future industrial chemical needs while alleviating the stress on Earth’s environment for the betterment of all life that it supports.

Source:  Pacific Northwest National Lab

Our IP Portfolio

Phytonix has an international patent and patent-pending IP portfolio for bio-safe renewable chemicals production.
Read more

Our Technology

Phytonix’s proprietary technology will produce bio-butanol and bio-octanol from photosynthetic bacteria, carbon dioxide, sunlight, and water.
Read more

Target Market

Phytonix is targeting the $50 billion global industrial chemical market for higher alcohols (four to eight carbon alcohols and their isomers).
Read more

Our Competitive Advantage

Phytonix’s technology has many advantages over other chemical production technologies. It utilizes carbon dioxide as the sole feedstock, avoiding food vs. fuel issues and the high costs associated with biomass sourcing and logistics. Phytonix’s production process is significantly carbon-negative. Fermentation-based technologies produce large amounts of carbon dioxide as a waste product. Our n-butanol production process replaces a fossil-based, carbon-intensive production process used by the worlds largest chemical companies. We employ a collaborative business model and work with world class scientific and engineering teams for development and commercialization.

Read more

Phytonix featured in MIT Technology Review (German edition, May 2018)

Phytonix Corporation was recently featured in a German Technology Review Article. The bio-economy section article discussed the latest innovations in carbon dioxide utilization technology.

German Technology Review, May 2018, pp 92-94 

Nature Journal- Biotechnology Edition

Click the link below to read the feature of Phytonix in the Nature Journal’s Biotechnology Edition.

“Industrial Biotechs Turn Greenhouse Gas into Feedstock Opportunity”

 

https://www.slideshare.net/GordonSkene1/phytonix-article-2015-nov-nature-biotechnology

Phytonix Corporation Featured in Industrial Biorenewables: A Practical Viewpoint

Phytonix Corporation’s Founder and CEO, Bruce Dannenberg, is the lead author for Chapter 21 “Phytonix: Cyanobacteria for Biobased Production Using CO2”.

The following is an overview of what the chapter entails.

Phytonix’s photobiological process uses carbon dioxide as the sole, nonbiomass feedstock and along with solar energy and water produces the desired biofuel/chemical with only oxygen and residual biomass as by‐products. The Phytonix technology/IP essentially takes the key genetic code/genes for a butanol synthesis pathway from nonphotosynthetic organisms and engineers them into the genome of a photosynthetic cyanobacteria. Thus, this enables butanol to be generated via a photosynthetic/photobiological engine, using carbon dioxide as the sole feedstock/carbon source. The Phytonix photosynthetic process takes place in cyanobacteria as aquatic‐based photosynthetic microorganism. Phytonix’s full production process requires both an organism as well as the equipment to grow the organisms for the direct secretion of liquid n‐butanol into the culture media and a back‐end process for the separation of the butanol from the water‐based culture solution. Butanol is a valuable industrial chemical with a wholesale global market size of ten billion dollars.

Phytonix’s CEO made a Keynote Presentation at the International Conference on Synthetic Biology- Paris, France- July 16-17, 2018

The International Conference on Synthetic Biology hosted by Meetings International was held in Paris, France this July for leaders within the Synthetic Biology field to gather and discuss the latest developments with upcoming technologies.

Bruce Dannenberg, President and CEO of Phytonix, accepted an invitation and made a keynote presentation on the current and upcoming advancements in the technologies of Phytonix Corporation.

To learn more about this conference click the link below.

https://www.meetingsint.com/conferences/syntheticbiology

Mr. Bruce Dannenberg of Phytonix Corporation chaired and presented at the CO2 Reuse Summit- Zurich, Switzerland May 16-17, 2018

President and CEO of Phytonix Corporation, Bruce Dannenberg, accepted an invitation to chair and present at the  CO2 Reuse Summit hosted by Cogiton Group this past May in Zurich, Switzerland. This conference is dedicated to building the industry of Carbon Dioxide Utilization in order to move towards a decarbonized future.

Mr. Dannenberg made a presentation entitled “Biological Carbon Dioxide Utilization Technology for the Production of Low Cost Industrial Chemicals Utilizing Photosynthesis” in addition to chairing both days of the conference.

To learn more about additional speakers and sponsors of this conference follow the link below.

https://agribiostimulants.com/assets/files/CO2%20Reuse%20Agenda.pdf

Event: 10th Carbon Dioxide Utilization Summit- Tampa, FL, USA – February 28- March 1, 2018

ACI’s 10th Carbon Dioxide Utilization Summit follows on from a successful series of conferences focusing on the re-use of greenhouse gas CO2 and converting this into profitable sustainable materials. The two day conference brings together senior experts from various CO2 emitting industries discussing the sustainable, technological and commercial aspects of CO2 Utilization in North America and across the globe.

Mr. Bruce Dannenberg, Founder and CEO of Phytonix Corporation, has chaired and presented at this conference four consecutive years.

As Summit Chairman, Mr. Dannenberg provided opening and closing remarks each day, led meaningful discussions about the future of Carbon Dioxide Utilization, and presented current and upcoming Phytonix advancements.

For further details please visit:  http://www.wplgroup.com/aci/event/co2-us/

Phytonix’s CEO presented and participated in a panel discussion at a high-profile study on “Future Biotechnology Products and Opportunities to Enhance Capabilities of the Biotechnology Regulatory System” at the request of the U.S. EPA, USDA, FDA and the White House Office of Science and Technology Policy on June 27th, 2016 in San Francisco USA

Mr. Bruce Dannenberg, President and CEO of Phytonix Corporation, accepted an invitation to participate in and present at the one-day information-gathering meeting organized by The National Academies of Sciences, Engineering, and Medicine to answer the questions “What will the likely future products of biotechnology be over the next 5-10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology?”

Mr. Dannenberg provided the committee with important and valuable insights in regards to Phytonix’s breakthrough technology and it’s leadership approach for the utilization of both passive and active (proprietary) strategies and technology for the bio-safety guarded photobiological production of sustainable chemicals. This could provide a framework for future self-regulatory approaches and how these types of approaches might relate to appropriate future levels of mandated regulations.

To view Mr. Dannenberg’s presentation click the link below.

https://player.vimeo.com/video/173649710

“Phytonix Turns Photosynthetic Bacteria Into Tiny Chemical Factories”, Xconomy, 12/15/14

http://www.xconomy.com/raleigh-durham/2014/12/15/phytonix-turns-photosynthetic-bacteria-into-tiny-chemical-factories/

Phytonix in the News: Asheville entrepreneur aims to harness cyanobacteria’s photosynthetic prowess

Click on the link below to view the 05/12/2014 feature newspaper article on Phytonix and It’s founder, Bruce Dannenberg:

 

http://www.charlotteobserver.com/news/science-technology/article9119270.html